CTXR
Price
$1.39
Change
-$0.01 (-0.72%)
Updated
Jul 31, 03:34 PM (EDT)
Capitalization
15.53M
HYPD
Price
$8.68
Change
+$0.80 (+10.15%)
Updated
Jul 31, 02:36 PM (EDT)
Capitalization
44.15M
Interact to see
Advertisement

CTXR vs HYPD

Header iconCTXR vs HYPD Comparison
Open Charts CTXR vs HYPDBanner chart's image
Citius Pharmaceuticals
Price$1.39
Change-$0.01 (-0.72%)
Volume$330
Capitalization15.53M
Hyperion DeFi
Price$8.68
Change+$0.80 (+10.15%)
Volume$100
Capitalization44.15M
CTXR vs HYPD Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. HYPD commentary
Jul 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and HYPD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 31, 2025
Stock price -- (CTXR: $1.39 vs. HYPD: $7.88)
Brand notoriety: CTXR and HYPD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 13% vs. HYPD: 9%
Market capitalization -- CTXR: $15.53M vs. HYPD: $44.15M
CTXR [@Biotechnology] is valued at $15.53M. HYPD’s [@Biotechnology] market capitalization is $44.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $239.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileHYPD’s FA Score has 0 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • HYPD’s FA Score: 0 green, 5 red.
According to our system of comparison, HYPD is a better buy in the long-term than CTXR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while HYPD’s TA Score has 3 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 5 bearish.
  • HYPD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both CTXR and HYPD are a bad buy in the short-term.

Price Growth

CTXR (@Biotechnology) experienced а -15.76% price change this week, while HYPD (@Biotechnology) price change was -15.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.36%. For the same industry, the average monthly price growth was +18.42%, and the average quarterly price growth was +42.61%.

Reported Earning Dates

CTXR is expected to report earnings on May 14, 2025.

HYPD is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Biotechnology (+0.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPD($44.2M) has a higher market cap than CTXR($15.5M). HYPD YTD gains are higher at: 5297.261 vs. CTXR (-65.250). HYPD has higher annual earnings (EBITDA): -39.11M vs. CTXR (-42.77M). HYPD has higher revenues than CTXR: HYPD (67.1K) vs CTXR (0).
CTXRHYPDCTXR / HYPD
Capitalization15.5M44.2M35%
EBITDA-42.77M-39.11M109%
Gain YTD-65.2505297.261-1%
P/E RatioN/AN/A-
Revenue067.1K-
Total Cash26.4KN/A-
Total Debt932KN/A-
FUNDAMENTALS RATINGS
CTXR vs HYPD: Fundamental Ratings
CTXR
HYPD
OUTLOOK RATING
1..100
6674
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
5634
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (8) in the Pharmaceuticals Major industry is somewhat better than the same rating for HYPD (45). This means that CTXR’s stock grew somewhat faster than HYPD’s over the last 12 months.

HYPD's Profit vs Risk Rating (58) in the Pharmaceuticals Major industry is somewhat better than the same rating for CTXR (100). This means that HYPD’s stock grew somewhat faster than CTXR’s over the last 12 months.

CTXR's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as HYPD (100). This means that CTXR’s stock grew similarly to HYPD’s over the last 12 months.

HYPD's Price Growth Rating (34) in the Pharmaceuticals Major industry is in the same range as CTXR (56). This means that HYPD’s stock grew similarly to CTXR’s over the last 12 months.

HYPD's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as CTXR (100). This means that HYPD’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXRHYPD
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HYPD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FATBB2.670.17
+6.63%
FAT Brands
GIL51.63-0.27
-0.52%
Gildan Activewear
TXN189.52-1.86
-0.97%
Texas Instruments
CCEC23.45-0.85
-3.50%
Capital Clean Energy Carriers Corp
MSIF15.40-0.67
-4.17%
MSC Income Fund Inc.

HYPD and

Correlation & Price change

A.I.dvisor indicates that over the last year, HYPD has been loosely correlated with CTXR. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HYPD jumps, then CTXR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPD
1D Price
Change %
HYPD100%
-10.05%
CTXR - HYPD
37%
Loosely correlated
-5.44%
QNTM - HYPD
34%
Loosely correlated
+1.18%
INKT - HYPD
34%
Loosely correlated
-0.96%
VACBF - HYPD
32%
Poorly correlated
N/A
ACXP - HYPD
30%
Poorly correlated
-12.52%
More